On 8 July, Fundación Mutua Madrileña presented its 23rd Medical Research Grants, endowed with 2.3 million euros, to 21 new…
featured news
The Vall d’Hebron Institute of Oncology (VHIO) has launched an auction of artworks by artist Esperanza Pérez. This is an…
The European Society for Medical Oncology Congress on Gastrointestinal Cancers (ESMO GI) was held in Berlin from 1st to 4th…
Coinciding with World Kidney Cancer Day, on 20 June La Colla Vella dels Xiquets de Valls organised a moving event…
Published in The Lancet, results of the phase III COMPETE clinical trial show that the targeted radiotherapeutic agent [177Lu]Lu-edotreotide significantly…
Large-Scale Cancer Genomics Data Reveals Biomarkers That Might Spare Patients Ineffective Treatments
A study led by the Computational Immunogenomics Group at the Vall d’Hebron Institute of Oncology (VHIO), in collaboration with the…
On 31 May, Sant Quirze del Vallès hosted the first edition of the “Caminem per la Vida” charity walk, an…
The Vall d’Hebron Institute of Oncology (VHIO) has renewed its accreditation as a Severo Ochoa Centre of Excellence, the highest…
Dr Francisco Martínez-Jiménez, Head of the Computational Immunogenomics Group at the Vall d’Hebron Institute of Oncology (VHIO), has been awarded…
Why is there still no universal cure for cancer? How do researchers know whether treatment works? Why does cancer develop?…
